Immunotherapy, PRRT and the New Sequencing Challenge / atezolizumab/bevacizumab, Biliary tract cancer, CABINET Trial, ...

Perspective Therapeutics, Inc. announced new interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET in patients with unresectable or metastatic somatostatin receptor type 2 ...

Results presented at ESMO show a promising therapeutic index for [212Pb]VMT-α-NETDurable disease control in all three cohorts and 72% PFS at 18 ...

Scientists discovered that the hormone helping your body recover during sleep can also signal your brain to wake up.

Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in ...

There are about 106 peptide and nanobody drug conjugates in active development, and around 63% of them are still preclinical, according to a 2026 Citeline analysis of Pharmaprojects data.¹ For most of ...

A Dravet syndrome (DS) mouse model showed changes in inhibitory interneurons in the striatum that may contribute to ...

In HD brain tissue, researchers found age-independent changes in cortical interneurons, suggesting alterations may occur in ...

Perspective Therapeutics' lead-212 radiopharmaceutical shows responses in neuroendocrine tumor trial, with interim Phase 1/2a data presented at European nuclear ...

Co-commissioned by the Los Angeles Philharmonic, the London Symphony Orchestra, the Melbourne Symphony Orchestra and the ...